ArticleJournal of medical case reports2026
Acute hepatitis with synchronous acalculous cholecystitis and pancreatitis in a patient with Epstein-Barr viral infection: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpstein-Barr virus infection is common. However, to our knowledge, it has never been reported to cause synchronous acute acalculous cholecystitis and acute pancreatitis alongside hepatitis. This case highly suggests the potential for novel multiorgan involvement. CASE PRESENTATION: A 32-year-old Asian male patient presented with high-grade fever, abdominal pain, and jaundice. Comprehensive diagnostic evaluation confirmed acute hepatitis, acute acalculous cholecystitis, and acute pancreatitis. Histopathological examination of lymph node and liver biopsy specimens identified Epstein-Barr virus infection as the underlying cause of all three conditions. The patient was treated with dexamethasone at a dose of 5 mg per day combined with acyclovir. Significant clinical improvement was observed, and the patient was subsequently discharged.
conclusionThis is the first reported case of concurrent Epstein-Barr-virus-induced hepatitis, acute acalculous cholecystitis, and acute pancreatitis. The patient's full recovery through nonsurgical management, including antiviral and antiinflammatory therapies, may provide valuable insights for future clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.